View Financial HealthLevima Advanced Materials 배당 및 자사주 매입배당 기준 점검 1/6Levima Advanced Materials 수익으로 충분히 충당되는 현재 수익률 0.28% 보유한 배당금 지급 회사입니다.핵심 정보0.3%배당 수익률n/a자사주 매입 수익률총 주주 수익률n/a미래 배당 수익률0.3%배당 성장률-21.5%다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향24%최근 배당 및 자사주 매입 업데이트공시 • Apr 23Levima Advanced Materials Corporation Approves Cash Dividend on A Shares for the Year 2024, Payable on April 29, 2025Levima Advanced Materials Corporation at its Annual General Meeting held on 18 April 2025, approved the Cash dividend (tax included) on A shares of CNY 0.60000000 per 10 shares for the year 2024. Record date is 28 April 2025. Ex-date is 29 April 2025. Payment date is 29 April 2025.공시 • Mar 29Levima Advanced Materials Corporation Proposes Final Cash Dividend for the Year 2024Levima Advanced Materials Corporation announced the profit distribution proposal for the year 2024 as final cash dividend (tax included) of CNY 0.60000000 per 10 shares.Declared Dividend • Apr 20Dividend reduced to CN¥0.08Dividend of CN¥0.08 is 60% lower than last year. Ex-date: 25th April 2024 Payment date: 25th April 2024 Dividend yield will be 0.5%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (24% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has decreased over the past 36 years, indicating a lack of growth and stability in payments. EPS is expected to grow by 85% over the next 3 years, which should provide support to the dividend and adequate earnings cover.Upcoming Dividend • Apr 28Upcoming dividend of CN¥0.20 per share at 0.7% yieldEligible shareholders must have bought the stock before 05 May 2023. Payment date: 05 May 2023. Payout ratio is a comfortable 26% but the company is not cash flow positive. Trailing yield: 0.7%. Lower than top quartile of Chinese dividend payers (2.0%). Lower than average of industry peers (1.9%).모든 업데이트 보기Recent updatesBoard Change • May 20Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 3 independent directors. 5 non-independent directors. Independent Director Na Sun was the last independent director to join the board, commencing their role in 2024. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity.공시 • Mar 31Levima Advanced Materials Corporation to Report Q1, 2026 Results on Apr 23, 2026Levima Advanced Materials Corporation announced that they will report Q1, 2026 results on Apr 23, 2026공시 • Mar 28Levima Advanced Materials Corporation, Annual General Meeting, Apr 20, 2026Levima Advanced Materials Corporation, Annual General Meeting, Apr 20, 2026, at 14:30 China Standard Time. Location: The Company's Meeting Room, Beijing China공시 • Dec 31Levima Advanced Materials Corporation to Report Fiscal Year 2025 Results on Mar 28, 2026Levima Advanced Materials Corporation announced that they will report fiscal year 2025 results on Mar 28, 2026공시 • Sep 30Levima Advanced Materials Corporation to Report Q3, 2025 Results on Oct 15, 2025Levima Advanced Materials Corporation announced that they will report Q3, 2025 results on Oct 15, 2025공시 • Jul 02Levima Advanced Materials Corporation to Report First Half, 2025 Results on Aug 16, 2025Levima Advanced Materials Corporation announced that they will report first half, 2025 results on Aug 16, 2025공시 • Apr 23Levima Advanced Materials Corporation Approves Cash Dividend on A Shares for the Year 2024, Payable on April 29, 2025Levima Advanced Materials Corporation at its Annual General Meeting held on 18 April 2025, approved the Cash dividend (tax included) on A shares of CNY 0.60000000 per 10 shares for the year 2024. Record date is 28 April 2025. Ex-date is 29 April 2025. Payment date is 29 April 2025.공시 • Mar 31Levima Advanced Materials Corporation to Report Q1, 2025 Results on Apr 26, 2025Levima Advanced Materials Corporation announced that they will report Q1, 2025 results on Apr 26, 2025공시 • Mar 29Levima Advanced Materials Corporation Proposes Final Cash Dividend for the Year 2024Levima Advanced Materials Corporation announced the profit distribution proposal for the year 2024 as final cash dividend (tax included) of CNY 0.60000000 per 10 shares.공시 • Mar 28Levima Advanced Materials Corporation, Annual General Meeting, Apr 18, 2025Levima Advanced Materials Corporation, Annual General Meeting, Apr 18, 2025, at 14:30 China Standard Time. Location: The Company's Meeting Room, Beijing China공시 • Dec 31Levima Advanced Materials Corporation to Report Fiscal Year 2024 Results on Mar 28, 2025Levima Advanced Materials Corporation announced that they will report fiscal year 2024 results on Mar 28, 2025New Risk • Nov 14New major risk - Revenue and earnings growthEarnings have declined by 13% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (10% operating cash flow to total debt). Earnings have declined by 13% per year over the past 5 years. Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (3.2% net profit margin).Reported Earnings • Oct 29Third quarter 2024 earnings released: EPS: CN¥0.024 (vs CN¥0.059 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.024 (down from CN¥0.059 in 3Q 2023). Revenue: CN¥1.65b (down 4.4% from 3Q 2023). Net income: CN¥37.6m (down 52% from 3Q 2023). Profit margin: 2.3% (down from 4.5% in 3Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China.공시 • Sep 30Levima Advanced Materials Corporation to Report Q3, 2024 Results on Oct 26, 2024Levima Advanced Materials Corporation announced that they will report Q3, 2024 results on Oct 26, 2024Valuation Update With 7 Day Price Move • Sep 27Investor sentiment improves as stock rises 17%After last week's 17% share price gain to CN¥14.77, the stock trades at a forward P/E ratio of 32x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 24% over the past year.Board Change • Sep 03High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Na Sun was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Aug 01Second quarter 2024 earnings released: EPS: CN¥0.07 (vs CN¥0.13 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.07 (down from CN¥0.13 in 2Q 2023). Revenue: CN¥1.83b (up 12% from 2Q 2023). Net income: CN¥89.3m (down 50% from 2Q 2023). Profit margin: 4.9% (down from 11% in 2Q 2023). Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China.공시 • Jun 29Levima Advanced Materials Corporation to Report First Half, 2024 Results on Jul 27, 2024Levima Advanced Materials Corporation announced that they will report first half, 2024 results on Jul 27, 2024Reported Earnings • Apr 28First quarter 2024 earnings released: EPS: CN¥0.04 (vs CN¥0.11 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.04 (down from CN¥0.11 in 1Q 2023). Revenue: CN¥1.49b (down 5.6% from 1Q 2023). Net income: CN¥51.4m (down 65% from 1Q 2023). Profit margin: 3.5% (down from 9.3% in 1Q 2023). Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China.Declared Dividend • Apr 20Dividend reduced to CN¥0.08Dividend of CN¥0.08 is 60% lower than last year. Ex-date: 25th April 2024 Payment date: 25th April 2024 Dividend yield will be 0.5%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (24% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has decreased over the past 36 years, indicating a lack of growth and stability in payments. EPS is expected to grow by 85% over the next 3 years, which should provide support to the dividend and adequate earnings cover.공시 • Mar 30Levima Advanced Materials Corporation to Report Q1, 2024 Results on Apr 27, 2024Levima Advanced Materials Corporation announced that they will report Q1, 2024 results on Apr 27, 2024Reported Earnings • Mar 29Full year 2023 earnings released: EPS: CN¥0.33 (vs CN¥0.65 in FY 2022)Full year 2023 results: EPS: CN¥0.33 (down from CN¥0.65 in FY 2022). Revenue: CN¥6.78b (down 17% from FY 2022). Net income: CN¥446.1m (down 49% from FY 2022). Profit margin: 6.6% (down from 11% in FY 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 24% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Chemicals industry in China.공시 • Mar 27Levima Advanced Materials Corporation, Annual General Meeting, Apr 16, 2024Levima Advanced Materials Corporation, Annual General Meeting, Apr 16, 2024, at 14:30 China Standard Time. Location: The Company's Meeting Room, Beijing ChinaNew Risk • Feb 05New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.5x net interest cover). High level of non-cash earnings (28% accrual ratio). Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (6.6% average weekly change). Profit margins are more than 30% lower than last year (7.4% net profit margin).Valuation Update With 7 Day Price Move • Jan 31Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to CN¥14.36, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 14x in the Chemicals industry in China. Total loss to shareholders of 63% over the past year.공시 • Dec 30Levima Advanced Materials Corporation to Report Fiscal Year 2023 Results on Mar 27, 2024Levima Advanced Materials Corporation announced that they will report fiscal year 2023 results on Mar 27, 2024Reported Earnings • Oct 31Third quarter 2023 earnings released: EPS: CN¥0.059 (vs CN¥0.24 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.059 (down from CN¥0.24 in 3Q 2022). Revenue: CN¥1.73b (down 30% from 3Q 2022). Net income: CN¥78.4m (down 76% from 3Q 2022). Profit margin: 4.5% (down from 13% in 3Q 2022). Revenue is forecast to grow 25% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China.공시 • Sep 30Levima Advanced Materials Corporation to Report Q3, 2023 Results on Oct 26, 2023Levima Advanced Materials Corporation announced that they will report Q3, 2023 results on Oct 26, 2023New Risk • Jul 23New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 55% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Large one-off items impacting financial results.Upcoming Dividend • Apr 28Upcoming dividend of CN¥0.20 per share at 0.7% yieldEligible shareholders must have bought the stock before 05 May 2023. Payment date: 05 May 2023. Payout ratio is a comfortable 26% but the company is not cash flow positive. Trailing yield: 0.7%. Lower than top quartile of Chinese dividend payers (2.0%). Lower than average of industry peers (1.9%).Buying Opportunity • Mar 15Now 20% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be CN¥38.68, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 15% over the last 3 years. Earnings per share has grown by 20%. Revenue is forecast to grow by 49% in 2 years. Earnings is forecast to grow by 123% in the next 2 years.Valuation Update With 7 Day Price Move • Jan 06Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥35.24, the stock trades at a forward P/E ratio of 29x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 8.0% over the past year. Simply Wall St's valuation model estimates the intrinsic value at CN¥39.00 per share.Board Change • Nov 16High number of new and inexperienced directorsThere are 11 new directors who have joined the board in the last 3 years. The company's board is composed of: 11 new directors. No experienced directors. No highly experienced directors. Employee Representative Supervisor Jingjun Zhou is the most experienced director on the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Valuation Update With 7 Day Price Move • Nov 05Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥38.55, the stock trades at a forward P/E ratio of 32x. Average forward P/E is 15x in the Chemicals industry in China. Simply Wall St's valuation model estimates the intrinsic value at CN¥47.09 per share.Buying Opportunity • Oct 14Now 25% undervalued after recent price dropOver the last 90 days, the stock is down 2.4%. The fair value is estimated to be CN¥52.35, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.6% over the last year. Earnings per share has declined by 3.1%. Revenue is forecast to grow by 47% in 2 years. Earnings is forecast to grow by 104% in the next 2 years.Buying Opportunity • Sep 16Now 24% undervaluedOver the last 90 days, the stock is up 23%. The fair value is estimated to be CN¥57.48, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.6% over the last year. Earnings per share has declined by 3.1%. Revenue is forecast to grow by 48% in 2 years. Earnings is forecast to grow by 110% in the next 2 years.Valuation Update With 7 Day Price Move • Sep 07Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥48.13, the stock trades at a forward P/E ratio of 45x. Average forward P/E is 17x in the Chemicals industry in China. Simply Wall St's valuation model estimates the intrinsic value at CN¥58.50 per share.Buying Opportunity • Aug 31Now 20% undervaluedOver the last 90 days, the stock is up 72%. The fair value is estimated to be CN¥57.70, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.6% over the last year. Earnings per share has declined by 3.1%. Revenue is forecast to grow by 46% in 2 years. Earnings is forecast to grow by 83% in the next 2 years.Reported Earnings • Jul 29Second quarter 2022 earnings released: EPS: CN¥0.26 (vs CN¥0.21 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.26 (up from CN¥0.21 in 2Q 2021). Revenue: CN¥2.38b (up 18% from 2Q 2021). Net income: CN¥349.4m (up 29% from 2Q 2021). Profit margin: 15% (up from 13% in 2Q 2021). Over the next year, revenue is forecast to grow 22%, compared to a 42% growth forecast for the industry in China.Valuation Update With 7 Day Price Move • Jul 19Investor sentiment improved over the past weekAfter last week's 18% share price gain to CN¥40.50, the stock trades at a forward P/E ratio of 39x. Average forward P/E is 17x in the Chemicals industry in China. Simply Wall St's valuation model estimates the intrinsic value at CN¥57.37 per share.Valuation Update With 7 Day Price Move • Jun 11Investor sentiment improved over the past weekAfter last week's 24% share price gain to CN¥33.45, the stock trades at a forward P/E ratio of 34x. Average forward P/E is 18x in the Chemicals industry in China. Simply Wall St's valuation model estimates the intrinsic value at CN¥53.95 per share.Valuation Update With 7 Day Price Move • May 21Investor sentiment improved over the past weekAfter last week's 19% share price gain to CN¥25.47, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 16x in the Chemicals industry in China.Reported Earnings • Apr 27First quarter 2022 earnings released: EPS: CN¥0.08 (vs CN¥0.20 in 1Q 2021)First quarter 2022 results: EPS: CN¥0.08 (down from CN¥0.20 in 1Q 2021). Revenue: CN¥1.56b (down 14% from 1Q 2021). Net income: CN¥107.4m (down 60% from 1Q 2021). Profit margin: 6.9% (down from 15% in 1Q 2021). Over the next year, revenue is forecast to grow 27%, compared to a 43% growth forecast for the industry in China.Board Change • Apr 27High number of new and inexperienced directorsThere are 9 new directors who have joined the board in the last 3 years. The company's board is composed of: 9 new directors. 1 experienced director. No highly experienced directors. Non-Employee Supervisor Rongguang Liu is the most experienced director on the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Reported Earnings • Apr 06Full year 2021 earnings released: EPS: CN¥0.82 (vs CN¥0.56 in FY 2020)Full year 2021 results: EPS: CN¥0.82 (up from CN¥0.56 in FY 2020). Revenue: CN¥7.58b (up 28% from FY 2020). Net income: CN¥1.09b (up 70% from FY 2020). Profit margin: 14% (up from 11% in FY 2020). Over the next year, revenue is forecast to grow 21%, compared to a 48% growth forecast for the industry in China.Board Change • Dec 10High number of new and inexperienced directorsThere are 9 new directors who have joined the board in the last 3 years. The company's board is composed of: 9 new directors. 1 experienced director. No highly experienced directors. Non-Employee Supervisor Rongguang Liu is the most experienced director on the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 003022 10년 미만 동안 배당금을 지급해 왔으며 이 기간 동안 지급액은 휘발성이었습니다.배당금 증가: 003022 5 년 동안만 배당금을 지급해 왔으며 그 이후 지급액이 감소했습니다.배당 수익률 vs 시장Levima Advanced Materials 배당 수익률 vs 시장003022의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (003022)0.3%시장 하위 25% (CN)0.4%시장 상위 25% (CN)1.9%업계 평균 (Chemicals)1.2%분석가 예측 (003022) (최대 3년)0.3%주목할만한 배당금: 003022 의 배당금( 0.28% )은 CN 시장에서 배당금 지급자의 하위 25%( 0.36% )와 비교해 주목할 만하지 않습니다.고배당: 003022 의 배당금( 0.28% )은 CN 시장에서 배당금 지급자의 상위 25%( 1.94% )와 비교해 낮습니다.주주 대상 이익 배당수익 보장: 지급 비율 ( 24% )이 낮기 때문에 003022 의 배당금 지급은 수익으로 충분히 충당됩니다.주주 현금 배당현금 흐름 범위: 003022 배당금을 지급하고 있지만 회사에는 잉여현금흐름이 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YCN 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/24 00:10종가2026/05/22 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Levima Advanced Materials Corporation는 5명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Xiongwei JiaChina International Capital Corporation LimitedLin YangGuosen Securities Co., Ltd.Junjun ZhuHaitong International Research Limited2명의 분석가 더 보기
공시 • Apr 23Levima Advanced Materials Corporation Approves Cash Dividend on A Shares for the Year 2024, Payable on April 29, 2025Levima Advanced Materials Corporation at its Annual General Meeting held on 18 April 2025, approved the Cash dividend (tax included) on A shares of CNY 0.60000000 per 10 shares for the year 2024. Record date is 28 April 2025. Ex-date is 29 April 2025. Payment date is 29 April 2025.
공시 • Mar 29Levima Advanced Materials Corporation Proposes Final Cash Dividend for the Year 2024Levima Advanced Materials Corporation announced the profit distribution proposal for the year 2024 as final cash dividend (tax included) of CNY 0.60000000 per 10 shares.
Declared Dividend • Apr 20Dividend reduced to CN¥0.08Dividend of CN¥0.08 is 60% lower than last year. Ex-date: 25th April 2024 Payment date: 25th April 2024 Dividend yield will be 0.5%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (24% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has decreased over the past 36 years, indicating a lack of growth and stability in payments. EPS is expected to grow by 85% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
Upcoming Dividend • Apr 28Upcoming dividend of CN¥0.20 per share at 0.7% yieldEligible shareholders must have bought the stock before 05 May 2023. Payment date: 05 May 2023. Payout ratio is a comfortable 26% but the company is not cash flow positive. Trailing yield: 0.7%. Lower than top quartile of Chinese dividend payers (2.0%). Lower than average of industry peers (1.9%).
Board Change • May 20Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 3 independent directors. 5 non-independent directors. Independent Director Na Sun was the last independent director to join the board, commencing their role in 2024. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity.
공시 • Mar 31Levima Advanced Materials Corporation to Report Q1, 2026 Results on Apr 23, 2026Levima Advanced Materials Corporation announced that they will report Q1, 2026 results on Apr 23, 2026
공시 • Mar 28Levima Advanced Materials Corporation, Annual General Meeting, Apr 20, 2026Levima Advanced Materials Corporation, Annual General Meeting, Apr 20, 2026, at 14:30 China Standard Time. Location: The Company's Meeting Room, Beijing China
공시 • Dec 31Levima Advanced Materials Corporation to Report Fiscal Year 2025 Results on Mar 28, 2026Levima Advanced Materials Corporation announced that they will report fiscal year 2025 results on Mar 28, 2026
공시 • Sep 30Levima Advanced Materials Corporation to Report Q3, 2025 Results on Oct 15, 2025Levima Advanced Materials Corporation announced that they will report Q3, 2025 results on Oct 15, 2025
공시 • Jul 02Levima Advanced Materials Corporation to Report First Half, 2025 Results on Aug 16, 2025Levima Advanced Materials Corporation announced that they will report first half, 2025 results on Aug 16, 2025
공시 • Apr 23Levima Advanced Materials Corporation Approves Cash Dividend on A Shares for the Year 2024, Payable on April 29, 2025Levima Advanced Materials Corporation at its Annual General Meeting held on 18 April 2025, approved the Cash dividend (tax included) on A shares of CNY 0.60000000 per 10 shares for the year 2024. Record date is 28 April 2025. Ex-date is 29 April 2025. Payment date is 29 April 2025.
공시 • Mar 31Levima Advanced Materials Corporation to Report Q1, 2025 Results on Apr 26, 2025Levima Advanced Materials Corporation announced that they will report Q1, 2025 results on Apr 26, 2025
공시 • Mar 29Levima Advanced Materials Corporation Proposes Final Cash Dividend for the Year 2024Levima Advanced Materials Corporation announced the profit distribution proposal for the year 2024 as final cash dividend (tax included) of CNY 0.60000000 per 10 shares.
공시 • Mar 28Levima Advanced Materials Corporation, Annual General Meeting, Apr 18, 2025Levima Advanced Materials Corporation, Annual General Meeting, Apr 18, 2025, at 14:30 China Standard Time. Location: The Company's Meeting Room, Beijing China
공시 • Dec 31Levima Advanced Materials Corporation to Report Fiscal Year 2024 Results on Mar 28, 2025Levima Advanced Materials Corporation announced that they will report fiscal year 2024 results on Mar 28, 2025
New Risk • Nov 14New major risk - Revenue and earnings growthEarnings have declined by 13% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (10% operating cash flow to total debt). Earnings have declined by 13% per year over the past 5 years. Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (3.2% net profit margin).
Reported Earnings • Oct 29Third quarter 2024 earnings released: EPS: CN¥0.024 (vs CN¥0.059 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.024 (down from CN¥0.059 in 3Q 2023). Revenue: CN¥1.65b (down 4.4% from 3Q 2023). Net income: CN¥37.6m (down 52% from 3Q 2023). Profit margin: 2.3% (down from 4.5% in 3Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China.
공시 • Sep 30Levima Advanced Materials Corporation to Report Q3, 2024 Results on Oct 26, 2024Levima Advanced Materials Corporation announced that they will report Q3, 2024 results on Oct 26, 2024
Valuation Update With 7 Day Price Move • Sep 27Investor sentiment improves as stock rises 17%After last week's 17% share price gain to CN¥14.77, the stock trades at a forward P/E ratio of 32x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 24% over the past year.
Board Change • Sep 03High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Na Sun was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Aug 01Second quarter 2024 earnings released: EPS: CN¥0.07 (vs CN¥0.13 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.07 (down from CN¥0.13 in 2Q 2023). Revenue: CN¥1.83b (up 12% from 2Q 2023). Net income: CN¥89.3m (down 50% from 2Q 2023). Profit margin: 4.9% (down from 11% in 2Q 2023). Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China.
공시 • Jun 29Levima Advanced Materials Corporation to Report First Half, 2024 Results on Jul 27, 2024Levima Advanced Materials Corporation announced that they will report first half, 2024 results on Jul 27, 2024
Reported Earnings • Apr 28First quarter 2024 earnings released: EPS: CN¥0.04 (vs CN¥0.11 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.04 (down from CN¥0.11 in 1Q 2023). Revenue: CN¥1.49b (down 5.6% from 1Q 2023). Net income: CN¥51.4m (down 65% from 1Q 2023). Profit margin: 3.5% (down from 9.3% in 1Q 2023). Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China.
Declared Dividend • Apr 20Dividend reduced to CN¥0.08Dividend of CN¥0.08 is 60% lower than last year. Ex-date: 25th April 2024 Payment date: 25th April 2024 Dividend yield will be 0.5%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (24% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has decreased over the past 36 years, indicating a lack of growth and stability in payments. EPS is expected to grow by 85% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
공시 • Mar 30Levima Advanced Materials Corporation to Report Q1, 2024 Results on Apr 27, 2024Levima Advanced Materials Corporation announced that they will report Q1, 2024 results on Apr 27, 2024
Reported Earnings • Mar 29Full year 2023 earnings released: EPS: CN¥0.33 (vs CN¥0.65 in FY 2022)Full year 2023 results: EPS: CN¥0.33 (down from CN¥0.65 in FY 2022). Revenue: CN¥6.78b (down 17% from FY 2022). Net income: CN¥446.1m (down 49% from FY 2022). Profit margin: 6.6% (down from 11% in FY 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 24% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Chemicals industry in China.
공시 • Mar 27Levima Advanced Materials Corporation, Annual General Meeting, Apr 16, 2024Levima Advanced Materials Corporation, Annual General Meeting, Apr 16, 2024, at 14:30 China Standard Time. Location: The Company's Meeting Room, Beijing China
New Risk • Feb 05New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.5x net interest cover). High level of non-cash earnings (28% accrual ratio). Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (6.6% average weekly change). Profit margins are more than 30% lower than last year (7.4% net profit margin).
Valuation Update With 7 Day Price Move • Jan 31Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to CN¥14.36, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 14x in the Chemicals industry in China. Total loss to shareholders of 63% over the past year.
공시 • Dec 30Levima Advanced Materials Corporation to Report Fiscal Year 2023 Results on Mar 27, 2024Levima Advanced Materials Corporation announced that they will report fiscal year 2023 results on Mar 27, 2024
Reported Earnings • Oct 31Third quarter 2023 earnings released: EPS: CN¥0.059 (vs CN¥0.24 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.059 (down from CN¥0.24 in 3Q 2022). Revenue: CN¥1.73b (down 30% from 3Q 2022). Net income: CN¥78.4m (down 76% from 3Q 2022). Profit margin: 4.5% (down from 13% in 3Q 2022). Revenue is forecast to grow 25% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China.
공시 • Sep 30Levima Advanced Materials Corporation to Report Q3, 2023 Results on Oct 26, 2023Levima Advanced Materials Corporation announced that they will report Q3, 2023 results on Oct 26, 2023
New Risk • Jul 23New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 55% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Large one-off items impacting financial results.
Upcoming Dividend • Apr 28Upcoming dividend of CN¥0.20 per share at 0.7% yieldEligible shareholders must have bought the stock before 05 May 2023. Payment date: 05 May 2023. Payout ratio is a comfortable 26% but the company is not cash flow positive. Trailing yield: 0.7%. Lower than top quartile of Chinese dividend payers (2.0%). Lower than average of industry peers (1.9%).
Buying Opportunity • Mar 15Now 20% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be CN¥38.68, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 15% over the last 3 years. Earnings per share has grown by 20%. Revenue is forecast to grow by 49% in 2 years. Earnings is forecast to grow by 123% in the next 2 years.
Valuation Update With 7 Day Price Move • Jan 06Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥35.24, the stock trades at a forward P/E ratio of 29x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 8.0% over the past year. Simply Wall St's valuation model estimates the intrinsic value at CN¥39.00 per share.
Board Change • Nov 16High number of new and inexperienced directorsThere are 11 new directors who have joined the board in the last 3 years. The company's board is composed of: 11 new directors. No experienced directors. No highly experienced directors. Employee Representative Supervisor Jingjun Zhou is the most experienced director on the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Valuation Update With 7 Day Price Move • Nov 05Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥38.55, the stock trades at a forward P/E ratio of 32x. Average forward P/E is 15x in the Chemicals industry in China. Simply Wall St's valuation model estimates the intrinsic value at CN¥47.09 per share.
Buying Opportunity • Oct 14Now 25% undervalued after recent price dropOver the last 90 days, the stock is down 2.4%. The fair value is estimated to be CN¥52.35, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.6% over the last year. Earnings per share has declined by 3.1%. Revenue is forecast to grow by 47% in 2 years. Earnings is forecast to grow by 104% in the next 2 years.
Buying Opportunity • Sep 16Now 24% undervaluedOver the last 90 days, the stock is up 23%. The fair value is estimated to be CN¥57.48, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.6% over the last year. Earnings per share has declined by 3.1%. Revenue is forecast to grow by 48% in 2 years. Earnings is forecast to grow by 110% in the next 2 years.
Valuation Update With 7 Day Price Move • Sep 07Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥48.13, the stock trades at a forward P/E ratio of 45x. Average forward P/E is 17x in the Chemicals industry in China. Simply Wall St's valuation model estimates the intrinsic value at CN¥58.50 per share.
Buying Opportunity • Aug 31Now 20% undervaluedOver the last 90 days, the stock is up 72%. The fair value is estimated to be CN¥57.70, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.6% over the last year. Earnings per share has declined by 3.1%. Revenue is forecast to grow by 46% in 2 years. Earnings is forecast to grow by 83% in the next 2 years.
Reported Earnings • Jul 29Second quarter 2022 earnings released: EPS: CN¥0.26 (vs CN¥0.21 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.26 (up from CN¥0.21 in 2Q 2021). Revenue: CN¥2.38b (up 18% from 2Q 2021). Net income: CN¥349.4m (up 29% from 2Q 2021). Profit margin: 15% (up from 13% in 2Q 2021). Over the next year, revenue is forecast to grow 22%, compared to a 42% growth forecast for the industry in China.
Valuation Update With 7 Day Price Move • Jul 19Investor sentiment improved over the past weekAfter last week's 18% share price gain to CN¥40.50, the stock trades at a forward P/E ratio of 39x. Average forward P/E is 17x in the Chemicals industry in China. Simply Wall St's valuation model estimates the intrinsic value at CN¥57.37 per share.
Valuation Update With 7 Day Price Move • Jun 11Investor sentiment improved over the past weekAfter last week's 24% share price gain to CN¥33.45, the stock trades at a forward P/E ratio of 34x. Average forward P/E is 18x in the Chemicals industry in China. Simply Wall St's valuation model estimates the intrinsic value at CN¥53.95 per share.
Valuation Update With 7 Day Price Move • May 21Investor sentiment improved over the past weekAfter last week's 19% share price gain to CN¥25.47, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 16x in the Chemicals industry in China.
Reported Earnings • Apr 27First quarter 2022 earnings released: EPS: CN¥0.08 (vs CN¥0.20 in 1Q 2021)First quarter 2022 results: EPS: CN¥0.08 (down from CN¥0.20 in 1Q 2021). Revenue: CN¥1.56b (down 14% from 1Q 2021). Net income: CN¥107.4m (down 60% from 1Q 2021). Profit margin: 6.9% (down from 15% in 1Q 2021). Over the next year, revenue is forecast to grow 27%, compared to a 43% growth forecast for the industry in China.
Board Change • Apr 27High number of new and inexperienced directorsThere are 9 new directors who have joined the board in the last 3 years. The company's board is composed of: 9 new directors. 1 experienced director. No highly experienced directors. Non-Employee Supervisor Rongguang Liu is the most experienced director on the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Reported Earnings • Apr 06Full year 2021 earnings released: EPS: CN¥0.82 (vs CN¥0.56 in FY 2020)Full year 2021 results: EPS: CN¥0.82 (up from CN¥0.56 in FY 2020). Revenue: CN¥7.58b (up 28% from FY 2020). Net income: CN¥1.09b (up 70% from FY 2020). Profit margin: 14% (up from 11% in FY 2020). Over the next year, revenue is forecast to grow 21%, compared to a 48% growth forecast for the industry in China.
Board Change • Dec 10High number of new and inexperienced directorsThere are 9 new directors who have joined the board in the last 3 years. The company's board is composed of: 9 new directors. 1 experienced director. No highly experienced directors. Non-Employee Supervisor Rongguang Liu is the most experienced director on the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.